No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
478 |
4. Check minimum number of eventsNone |
478 |
5. Include endpointsNone |
478 |
6. Filter based on genotype QC (FinnGen only) |
478 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Laesio anoxica cerebri non alibi classificata
Similar endpoints
↥List of similar endpoints to
Anoxic brain damage
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7504 | 2213 | 5132 |
| Only index persons | 4082 | 1219 | 2863 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.06 | 0.14 |
| Only index persons | 0.09 | 0.04 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 60.56 | 61.03 | 60.15 |
| Only index persons | 60.34 | 60.12 | 60.43 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 478 | 128 | 350 |
| Unadjusted period prevalence (%) | 0.12 | 0.04 | 0.15 |
| Median age at first event (years) | 62.71 | 57.89 | 64.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 449
- Matched controls
- 4488
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
+∞
323.0
436
*
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
222.8
265.1
254
26
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
84.1
69.8
77
11
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.0
52.7
176
437
WX730
NOMESCO Finland
Conventional respirator
21.4
37.2
55
29
WX930
NOMESCO Finland
Thepapeutic hypothermia
+∞
32.7
31
*
AA1AD
NOMESCO Finland
CT of head and brain
3.6
28.0
159
598
WX872
NOMESCO Finland
Intensive care
7.5
27.1
67
103
I47.2
ICD-10 Finland
Ventricular tachycardia
14.2
26.3
45
35
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
44.2
23.9
29
7
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.2
21.7
71
156
A98
ICPC
Health maint/preventive medicine
0.4
21.3
259
3550
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
20.5
48
68
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.7
20.0
176
855
I46.9
ICD-10 Finland
Cardiac arrest, unspecified
48.3
19.4
23
5
N03AG01
ATC
valproic acid; systemic, rectal
6.3
19.0
52
92
I25.2
ICD-10 Finland
Old myocardial infarction
3.9
18.8
83
245
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
9.9
18.0
36
39
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.3
17.8
56
117
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.0
17.4
49
90
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
15.5
144
701
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
29.8
15.3
20
7
GBB00
NOMESCO Finland
Tracheostomy
11.4
15.2
28
26
N03AX14
ATC
levetiracetam; systemic
10.0
15.2
30
32
AN1
HP
Coronary angiography
3.0
14.7
93
357
3481A
ICD-9 Finland
Other conditions of brain, Anoxic brain damage
+∞
14.7
14
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.0
13.5
56
155
WX900
NOMESCO Finland
Resuscitation
26.7
13.5
18
7
I42.0
ICD-10 Finland
Dilated cardiomyopathy
6.8
12.9
32
50
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.3
12.9
140
728
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
+∞
12.6
12
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
12.5
51
139
Z2445
NOMESCO Finland
Psychologist
5.7
12.4
35
65
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
4.8
12.3
41
92
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
18.7
12.1
18
10
R4150
NOMESCO Finland
Neuropsychological rehabilitation
18.7
12.1
18
10
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
12.0
104
477
WX704
NOMESCO Finland
Intubation
4.3
12.0
45
114
Z02.4
ICD-10 Finland
Examination for driving licence
0.3
11.5
28
808
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.3
11.1
29
49
C09AA05
ATC
ramipril; oral
2.2
11.0
141
783
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
10.8
66
247
C07AB07
ATC
bisoprolol; oral
2.0
10.8
231
1575
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
8.5
10.4
22
27
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
33.4
10.4
13
*
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
33.4
10.4
13
*
B01AA03
ATC
warfarin; systemic
2.2
10.0
126
688
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.5
10.0
29
56
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.2
9.9
37
94
C01BD01
ATC
amiodarone; systemic
5.3
9.7
29
58
C03CA01
ATC
furosemide; systemic
2.0
9.7
166
1025
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.4
9.5
46
146
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
18.0
9.5
14
8
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
8.3
9.4
20
25
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
12.7
9.4
16
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
9.4
142
836
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.3
9.0
23
38
I50.1
ICD-10 Finland
Left ventricular failure
3.7
9.0
39
113
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.2
8.9
19
24
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
8.5
52
193
I50.0
ICD-10 Finland
Congestive heart failure
2.8
8.3
55
216
M01AH05
ATC
etoricoxib; oral
0.5
8.2
107
1675
WX882
NOMESCO Finland
High dependency care
4.8
8.1
26
57
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
8.1
46
163
N05AX08
ATC
risperidone; systemic
2.9
8.1
48
177
ZXD05
NOMESCO Finland
Urgent procedure
1.9
8.0
148
931
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
8.0
53
207
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.1
7.9
44
154
G41.9
ICD-10 Finland
Status epilepticus, unspecified
15.4
7.7
12
8
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
45.8
7.7
9
*
X70
ICD-10 Finland
Intentional self-harm by hanging, strangulation and suffocation
45.8
7.7
9
*
XA400
NOMESCO Finland
EEG
45.8
7.7
9
*
183
Kela drug reimbursment
Lamotrigin and topiramate
18.7
7.6
11
6
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.1
7.6
15
17
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.5
7.4
59
257
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
7.4
86
450
G93.0
ICD-10 Finland
Cerebral cysts
+∞
7.3
7
*
I21.00
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
5.6
7.3
20
37
F60.9
ICD-10 Finland
Personality disorder, unspecified
16.1
7.3
11
7
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
7.1
72
354
WX890
NOMESCO Finland
Intesive care monitoring
9.0
7.1
14
16
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
6.8
122
750
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
40.7
6.8
8
*
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
17.0
6.8
10
6
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
5.1
6.7
20
41
N29
ICPC
Neurological sympt/complt other
6.6
6.7
16
25
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
6.7
29
86
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
5.5
6.5
18
34
R40.2
ICD-10 Finland
Coma, unspecified
8.3
6.4
13
16
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.9
6.3
36
129
XF409
NOMESCO Finland
Other special ECG
18.3
6.3
9
5
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.9
6.3
36
130
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
6.3
6
*
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
6.3
6
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
6.3
6
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.2
6.2
18
36
R55
ICD-10 Finland
Syncope and collapse
2.3
6.2
57
266
N18
ICPC
Paralysis/weakness
5.5
6.2
17
32
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
6.1
83
461
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
12.7
6.1
10
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
6.1
54
250
N05AH03
ATC
olanzapine; systemic
3.3
6.1
29
93
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
10.2
6.1
11
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.0
75
402
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000963) Hemoglobin [Mass/volume] in Blood
293
3928
0.34
26.83
34.7
23.0
g/l
131.2
135.9
4.67
287
3854
(3010813) Leukocytes [#/volume] in Blood
293
3927
0.34
26.76
34.5
22.9
e9/l
7.4
6.9
3.50
281
3799
(3026361) Erythrocytes [#/volume] in Blood
293
3926
0.34
26.69
34.5
22.8
e12/l
4.3
4.5
5.42
280
3798
(3035941) MCH [Entitic mass]
293
3925
0.35
26.62
34.3
22.7
pg
30.5
30.4
0.27
287
3858
(3024731) MCV [Entitic volume]
293
3924
0.35
26.55
34.4
22.8
fl
91.7
91.3
0.73
287
3857
(3007461) Platelets [#/volume] in Blood
293
3924
0.35
26.55
34.6
22.9
e9/l
232.4
239.0
0.89
279
3812
(3020779) Urea [Moles/volume] in Serum or Plasma
98
342
3.35
22.65
8.8
8.2
mmol/l
9.0
10.9
1.63
91
323
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
247
3494
0.39
21.96
5.4
5.0
mmol/l
2.4
2.6
4.99
229
3167
(40761511) CBC panel - Blood by Automated count
273
3688
0.39
21.25
23.9
14.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
236
3386
0.40
21.15
4.8
4.5
mmol/l
1.3
1.4
0.61
222
3072
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
230
3305
0.41
19.80
20.9
14.9
ml/min/173m2
81.0
78.1
0.85
195
2759
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
285
3753
0.40
19.74
13.4
10.7
u/l
35.2
27.2
1.42
275
3611
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
244
3415
0.42
19.41
5.0
4.5
mmol/l
4.2
4.5
3.32
226
3127
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
244
3409
0.42
19.14
4.9
4.6
mmol/l
6.2
6.1
0.36
221
3061
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
231
3274
0.43
18.12
6.8
6.1
mmol/mol
41.1
40.7
0.26
219
3014
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
235
3294
0.44
17.53
4.6
4.0
mmol/l
1.4
1.3
0.44
218
2976
(3009542) Hematocrit [Volume Fraction] of Blood
225
3203
0.44
17.38
28.7
17.1
%
38.9
39.7
0.52
138
2222
(3023103) Potassium [Moles/volume] in Serum or Plasma
290
3687
0.46
14.69
32.3
18.7
mmol/l
4.0
4.0
0.10
281
3571
(3019550) Sodium [Moles/volume] in Serum or Plasma
291
3677
0.47
13.93
32.8
18.5
mmol/l
138.9
139.7
2.77
285
3566
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
46
1159
0.33
12.21
2.6
3.0
ug/l
0.6
0.8
1.40
34
773
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
121
2024
0.46
12.14
2.6
2.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
232
3105
0.51
11.78
5.3
4.2
mu/l
2.2
2.0
0.69
215
2761
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
119
1984
0.47
11.65
3.7
5.2
ug/l
2.0
3.7
1.94
101
1745
(3003396) Base excess in Arterial blood by calculation
94
453
2.34
11.22
12.9
8.9
mmol/l
0.4
1.2
0.80
71
345
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
287
3571
0.51
11.17
24.8
15.7
mg/l
31.1
26.8
1.25
246
2886
(3023183) Ammonium ion [Moles/volume] in Plasma
33
92
3.78
10.55
1.6
3.6
umol/l
36.8
34.3
0.13
26
77
(3013707) Erythrocyte sedimentation rate by Westergren method
186
2626
0.52
10.53
4.1
4.0
mm/h
13.8
13.2
0.17
176
2389
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
92
452
2.28
10.45
13.7
8.9
kpa
5.3
5.1
0.51
86
425
(3027801) Oxygen [Partial pressure] in Arterial blood
92
452
2.28
10.45
13.7
8.9
kpa
13.1
11.3
1.54
85
428
(3012095) Magnesium [Moles/volume] in Serum or Plasma
111
600
2.11
9.91
5.8
3.6
mmol/l
0.9
0.8
0.88
104
558
(3003458) Phosphate [Moles/volume] in Serum or Plasma
96
493
2.19
9.76
7.5
6.2
mmol/l
1.1
1.0
1.82
89
451
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
91
1588
0.47
9.50
4.1
4.4
%
22.0
21.4
0.14
38
779
(3019060) Gas panel - Arterial blood
60
260
2.50
8.98
10.2
5.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
343
2.26
8.32
3.4
2.7
ug/l
25.7
7.5
2.00
65
303
(1761868) Lipid panel - Serum or Plasma
64
1179
0.47
7.36
3.6
2.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
135
2.63
6.09
3.6
2.6
u/ml
0.3
0.3
0.21
21
79
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
178
2.36
5.66
2.6
2.0
ug/l
0.9
1.7
0.70
35
154
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
7
13.07
5.60
5.4
10.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
29
4.58
5.54
1.3
1.5
promille
1.2
1.3
—
8
22
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
262
2.10
5.47
2.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
90
1362
0.58
5.07
2.2
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
198
2484
0.65
4.86
6.1
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
198
2472
0.66
4.66
4.5
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
84
534
1.70
4.33
34.1
28.4
inr
1.5
1.3
0.56
14
75
(3021601) Nitrite [Presence] in Urine by Test strip
124
1678
0.65
4.15
5.4
5.1
estimate
0.0
0.0
0.00
26
328
(3039443) Prostate specific Ag panel - Serum or Plasma
0
104
0.00
4.07
0.0
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
7
10.12
4.02
5.0
10.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
59
347
1.80
3.98
5.3
2.9
ng/l
241.6
252.1
0.08
54
314
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
142
1049
1.50
3.85
2.8
2.2
u/l
332.1
350.1
0.06
133
983
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
111
1516
0.65
3.80
2.4
2.0
pmol/l
101.1
92.1
1.21
63
833
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
187
2307
0.69
3.78
4.4
3.3
u/l
74.3
54.8
1.76
165
2147
(3032080) INR in Blood by Coagulation assay
196
1548
1.45
3.78
15.5
11.4
inr
1.4
1.3
0.16
52
428
(3020891) Body temperature
30
142
2.19
3.73
16.8
4.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
129
1704
0.67
3.73
4.3
3.7
estimate
0.0
0.0
0.00
26
309
(3035350) Ketones [Presence] in Urine by Test strip
129
1699
0.67
3.66
4.3
3.6
estimate
0.0
0.0
0.00
27
322
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
237
2791
0.70
3.61
9.2
7.9
u/l
84.0
80.9
0.34
229
2611
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
203
2455
0.70
3.60
4.3
3.5
pmol/l
15.0
14.8
0.46
185
2180
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
6
10.10
3.50
5.2
11.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
68
1016
0.61
3.44
3.1
2.9
umol/l
372.1
7493.7
4.18
56
870
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
14
5.79
3.35
3.1
4.8
%
78.9
110.7
—
8
14
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
213
1.90
3.33
15.6
13.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
165
2050
0.70
3.31
10.1
9.3
e9/l
4.6
4.2
1.27
153
1798
(21494755) Public health laboratory ask at order entry panel
10
291
0.33
3.30
1.2
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
252
0.34
3.27
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
21
440
0.45
3.27
1.3
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
11
6.44
3.19
5.0
5.4
—
—
—
0
0
(3013512) EKG study
80
1134
0.65
3.17
5.9
4.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
44
3.01
3.16
2.8
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
63
938
0.62
3.11
1.6
1.6
nmol/l
22.6
19.8
0.67
56
800
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
504
0.51
3.03
1.7
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
196
2338
0.73
2.94
4.7
4.4
e6/l
127.6
1978.9
—
5
44
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
510
0.52
2.91
1.2
1.2
u/ml
1.4
11.3
—
10
196
(4198724)
6
9
6.73
2.87
1.7
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
137
1723
0.71
2.82
7.0
6.0
%
24.1
26.6
1.57
132
1603
(3001122) Ferritin [Mass/volume] in Serum or Plasma
117
1507
0.70
2.76
3.6
2.7
ug/l
165.9
162.3
0.06
104
1378
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
513
0.54
2.74
1.3
1.3
iu/ml
20.7
39.3
—
9
167
(3018010) Neutrophils/100 leukocytes in Blood
135
1693
0.72
2.70
7.3
5.8
%
60.1
58.0
1.13
130
1589
(3049717) Cytology report of Urine Cyto stain
7
197
0.35
2.59
2.0
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
683
0.61
2.57
2.9
2.9
e6/l
0.7
0.9
0.57
26
413
(3007853) Bacteria identified in Skin by Aerobe culture
69
476
1.53
2.54
2.4
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
136
1682
0.73
2.43
7.2
6.1
%
8.5
9.0
0.82
130
1578
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
42
650
0.61
2.42
2.8
3.1
e6/l
1.0
1.4
0.42
24
383
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
65
913
0.67
2.41
1.8
1.7
mmol/l
1.4
1.4
0.05
60
763
(3018095) Leukocytes [#/volume] in Urine
105
1349
0.72
2.38
4.0
3.9
e6/l
204.2
119.5
0.29
81
989
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
670
0.62
2.37
1.3
1.3
u/ml
0.7
1.7
—
9
163
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
219
0.40
2.36
2.2
2.5
—
17.0
—
0
8
(3006504) Eosinophils/100 leukocytes in Blood
136
1676
0.74
2.36
6.9
5.8
%
2.7
2.9
0.24
131
1563
(3041096) Erythrocytes [Presence] in Urine by Automated
69
953
0.68
2.34
3.6
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
77
1040
0.69
2.32
3.7
3.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
133
1638
0.74
2.28
6.9
5.9
%
0.6
0.6
0.68
127
1534
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
104
1328
0.72
2.25
4.4
3.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
9
5.60
2.22
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
24
3.37
2.19
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
29
477
0.58
2.14
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
21
109
1.97
2.14
7.5
4.0
ph
7.4
7.4
0.52
15
88
(3023368) Bacteria identified in Blood by Culture
143
1161
1.33
2.11
5.3
4.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
84
1097
0.72
2.07
3.7
3.3
e6/l
0.9
0.5
0.37
70
833
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
163
1.76
2.03
3.7
3.5
pmol/l
4.1
4.5
1.16
23
140
(3012544) pH of Venous blood
55
381
1.50
2.01
8.8
4.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
152
1810
0.77
1.99
6.4
5.7
e9/l
1.7
1.8
0.84
141
1605
(3021589) Normoblasts [#/volume] in Blood
129
1568
0.76
1.96
13.5
9.9
e9/l
0.0
0.0
0.64
115
1280
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
58
2.28
1.92
3.5
1.7
u/l
145.9
390.2
—
6
16
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
200
0.44
1.88
1.1
1.3
—
62.0
—
0
11
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
73
2.09
1.82
2.6
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
156
1834
0.78
1.80
6.5
5.8
e9/l
0.2
0.2
0.13
143
1623
(3000764) Benzodiazepines [Presence] in Urine
18
95
1.93
1.77
3.2
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
95
1.93
1.77
3.2
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
95
1.93
1.77
3.2
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
95
1.93
1.77
3.3
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
46
651
0.68
1.77
1.3
1.4
g/l
2.2
2.6
0.82
28
398
(3020682) Albumin/Creatinine [Ratio] in Urine
96
1199
0.75
1.74
3.8
4.1
mg/mmol
15.7
11.9
0.22
73
809
(3012501) Base excess in Blood by calculation
17
89
1.94
1.72
7.9
4.2
mmol/l
3.6
2.4
—
8
58
(3003694) ABO and Rh group [Type] in Blood
76
978
0.73
1.69
1.5
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
150
1760
0.78
1.68
6.5
5.6
e9/l
0.6
0.6
0.54
138
1527
(3016879) Cocaine [Presence] in Urine
17
90
1.92
1.67
3.3
2.2
—
—
—
0
0
(1002224) Polysomnography panel
5
130
0.38
1.65
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
764
0.71
1.63
5.9
4.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
151
1765
0.79
1.62
6.4
5.6
e9/l
0.0
0.0
0.02
141
1545
(3023419) Bacteria identified in Sputum by Culture
12
56
2.17
1.62
1.4
2.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
97
1198
0.76
1.61
3.3
3.3
mmol/l
7.4
8.0
0.64
83
990
(3012516) Albumin [Mass/volume] in Urine
91
1132
0.76
1.59
3.2
3.4
mg/l
2095.1
321.8
0.90
68
770
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.4
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
377
0.62
1.51
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
65
2.03
1.50
3.5
3.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
37
2.46
1.48
2.1
2.8
—
—
—
0
0
(4306422)
9
37
2.46
1.48
1.2
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
98
1196
0.77
1.48
3.5
3.4
e6/l
72.8
144.4
0.58
79
933
(3025159) Blasts/100 leukocytes in Blood
17
285
0.58
1.40
3.8
4.3
%
0.0
0.1
—
5
81
(3002179) Metamyelocytes/100 leukocytes in Blood
17
284
0.58
1.38
4.1
4.1
%
0.4
0.4
—
5
75
(40768443) Skin Pathology biopsy report
8
164
0.48
1.38
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
41
2.22
1.37
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
112
1.73
1.37
1.4
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
89
719
1.29
1.34
6.2
3.8
ng/l
2385.4
336.5
0.80
79
585
(3044290) Cell count panel - Cerebral spinal fluid
11
54
2.06
1.33
1.4
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
115
1359
0.80
1.32
2.4
2.2
nmol/l
71.6
76.1
1.08
100
1208
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
24
2.52
1.30
1.0
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
13
69
1.91
1.29
1.5
1.2
mg/l
430.4
474.1
0.22
13
63
(3024928) Oxygen saturation in Venous blood
15
84
1.81
1.28
3.6
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
92
1.76
1.26
7.7
3.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
36
2.24
1.24
1.1
1.2
mosm/kgh2o
276.6
280.2
—
8
24
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
53
684
0.75
1.21
4.8
3.2
mmol/l
2.4
2.4
0.02
41
600
(3004616) Nuclear Ab [Presence] in Serum
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
111
0.44
1.14
1.6
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
7
30
2.35
1.12
1.0
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
315
0.65
1.12
3.7
4.2
%
1.3
0.8
—
9
102
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.4
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
265
0.63
1.08
1.5
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
770
0.78
1.07
4.5
3.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
141
1233
1.20
1.05
4.6
3.2
ng/l
2604.1
1914.7
0.64
131
1064
(3026008) Bacteria identified in Urine by Culture
119
1025
1.21
1.04
2.9
3.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
22
2.29
1.03
1.4
1.9
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
11
60
1.85
1.03
1.3
1.3
e6/l
1.7
9.2
0.88
11
47
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
11
60
1.85
1.03
1.4
1.4
e6/l
13.5
1982.9
0.56
11
49
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
46
353
1.34
1.02
3.1
2.5
g/l
0.2
0.2
0.28
40
327
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
48
1.89
1.01
1.3
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
248
0.63
1.00
2.6
2.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
295
0.66
1.00
3.6
4.3
%
0.3
0.1
—
8
93
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
11
61
1.82
0.99
1.4
1.1
mmol/l
3.8
3.7
0.18
11
56
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
121
1384
0.83
0.98
3.6
3.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
48
374
1.32
0.97
9.5
4.2
mmol/l
1.2
1.9
0.93
36
295
(3000991) Gas panel - Venous blood
43
331
1.33
0.95
22.0
9.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
27
192
1.43
0.94
11.0
3.4
mmol/l
24.0
25.3
1.32
27
186
(3020961) Endomysium IgA Ab [Titer] in Serum
9
154
0.58
0.90
1.2
1.1
—
32.2
—
0
5
(36660697) Celiac disease serology panel - Serum
15
228
0.65
0.88
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
72
1.68
0.86
2.4
3.3
e9/l
5.4
4.7
0.25
12
72
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
31
1.95
0.84
1.7
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
27
362
0.73
0.83
2.4
2.4
ug/g
446.9
137.2
0.46
20
289
(3000494) Fungus identified in Specimen by Culture
35
451
0.76
0.82
1.4
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
165
1493
1.16
0.81
4.8
3.9
ng/l
98.1
48.8
2.16
139
1092
(4035726)
23
315
0.72
0.80
1.7
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
24
0.00
0.79
0.0
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
33
1.83
0.79
3.3
2.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
25
0.00
0.79
0.0
2.6
—
529.1
—
0
20
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
25
0.00
0.79
0.0
1.3
—
134294.6
—
0
18
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
1.5
—
0
11
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
3.7
—
0
5
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
2.8
—
0
9
(40758558) Short blood count panel - Blood
74
867
0.83
0.78
9.9
7.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
27
0.00
0.77
0.0
2.2
—
612.5
—
0
11
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
129
1149
1.17
0.77
3.3
2.6
u/l
75.1
56.6
0.58
121
1067
(4024509)
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
345
0.74
0.76
1.7
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
75
1.62
0.75
2.7
3.9
%
60.5
57.5
0.29
12
75
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
100
1.52
0.73
1.2
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
56
1.62
0.72
1.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.0
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.3
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
143
0.62
0.70
1.6
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
41
1.72
0.70
4.0
3.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
118
0.59
0.68
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
203
0.68
0.68
2.5
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
91
0.54
0.67
1.0
1.3
—
75.0
—
0
6
(4094501)
5
94
0.53
0.67
1.8
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
95
0.52
0.67
1.0
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
130
1172
1.15
0.67
3.6
3.6
u/l
153.4
33.9
0.83
123
1112
(3021901) Oxygen saturation in Capillary blood
13
86
1.53
0.66
3.3
2.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
62
1.63
0.65
2.0
3.4
—
972.8
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
153
0.65
0.63
1.1
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
80
912
0.85
0.63
4.5
3.8
estimate
0.0
0.0
0.50
25
310
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.3
nmol/l
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
65
752
0.84
0.61
5.3
3.9
kg/l
1.0
1.0
1.01
11
105
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
161.5
—
0
20
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.5
—
81.8
—
0
21
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
97
1.46
0.59
1.2
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
68
781
0.85
0.59
3.4
3.0
mosm/kgh2o
545.3
580.2
0.82
57
655
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
229
1.28
0.58
1.9
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
116
0.60
0.58
1.9
1.6
nmol/l
46.7
41.6
—
7
109
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
403
1.21
0.58
6.5
3.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
18
240
0.74
0.57
2.1
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
206
0.72
0.56
3.7
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
40
480
0.82
0.56
2.1
3.9
u/l
312.1
253.9
1.09
35
450
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.0
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
46
387
1.21
0.55
2.2
1.9
%
1.9
1.6
1.39
40
338
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
66
1.53
0.53
1.3
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
33
401
0.81
0.52
2.8
4.5
ug/l
5.1
38.8
1.03
26
335
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
100
0.59
0.52
1.3
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
73
824
0.87
0.52
3.2
2.7
e6/l
5.5
4.1
0.56
65
718
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
64
1.41
0.51
2.9
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
75
1.48
0.51
1.3
1.6
—
—
—
0
0
(4010399)
29
234
1.25
0.51
1.3
1.4
—
—
—
0
0
(44790049)
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(44806118)
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(44790047)
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(44790048)
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
68
1.48
0.47
1.3
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
83
0.60
0.46
1.8
2.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
84
0.59
0.46
3.6
1.7
pmol/l
234.0
230.4
—
5
78
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
275
1.21
0.45
3.0
3.1
ml/min/173m2
65.1
64.5
0.04
22
118
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1932
1.10
0.44
7.3
6.7
umol/l
13.4
12.2
0.24
194
1828
(42870588) Differential panel, method unspecified - Blood
112
1216
0.90
0.44
5.9
5.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
92
1009
0.89
0.43
2.8
2.1
mg/l
3.3
3.1
0.32
74
860
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
92
0.65
0.42
1.5
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
139
0.71
0.42
3.1
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
32
1.57
0.42
3.8
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
35
296
1.20
0.42
5.1
3.7
mmol/l
1.2
1.2
1.15
29
263
(3024263) Appearance of Synovial fluid
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(44806420)
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
8.2
—
0
15
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
102
0.68
0.40
1.1
1.2
—
—
—
0
0
(4034850)
14
106
1.33
0.39
25.1
7.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
35
1.43
0.39
2.4
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
160
1.26
0.39
2.2
2.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
440
0.85
0.39
13.7
6.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(4268621)
5
36
1.39
0.38
2.4
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
168
1587
1.09
0.38
7.1
5.1
g/l
33.1
35.1
3.05
150
1482
(3037121) Protein [Mass/volume] in Urine
11
147
0.74
0.38
3.0
3.1
g/l
0.3
0.3
—
6
64
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
1.6
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
83
758
1.11
0.37
1.8
1.7
nmol/l
1225.2
1114.2
0.61
65
577
(3017732) Neutrophils [#/volume] in Blood
19
234
0.80
0.36
2.7
2.9
e9/l
3.7
4.2
0.88
13
177
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
288
0.82
0.36
1.5
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
81
1.37
0.36
1.0
1.1
—
3.3
—
0
8
(1761482) Bacteria [#/volume] in Urine by Culture
9
124
0.72
0.35
4.4
5.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
189
0.79
0.35
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
101
1.30
0.32
1.4
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
113
1205
0.92
0.31
4.3
3.5
mmol/l
2.3
2.3
0.10
103
1054
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
53
1.33
0.31
1.3
1.8
pg
30.7
33.4
—
7
53
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
53
1.33
0.31
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
100
0.70
0.31
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
100
0.70
0.31
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
31
356
0.86
0.30
3.1
4.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
55
1.28
0.30
5.7
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
186
1.19
0.28
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
104
1.26
0.26
1.5
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
123
1.23
0.25
1.6
2.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
85
795
1.08
0.25
1.6
1.8
pmol/l
445.3
8584752.6
0.50
72
664
(3037756) Immunofixation for Serum or Plasma
6
84
0.71
0.24
1.7
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
91
0.77
0.22
1.4
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
5.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
13
0.00
0.21
0.0
4.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
80
1.26
0.20
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
155
0.83
0.20
1.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4211845)
0
14
0.00
0.20
0.0
4.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
111
0.81
0.20
2.1
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
59
632
0.92
0.20
3.8
2.5
umol/l
11.4
12.7
0.84
53
584
(3021788) Differential panel - Synovial fluid
6
51
1.18
0.19
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
368
1.09
0.18
1.8
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
60
1.17
0.18
5.9
3.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
62
1.13
0.17
5.9
3.1
mmol/l
4.3
4.2
—
7
62
(3035285) Chloride [Moles/volume] in Venous blood
7
62
1.13
0.17
5.9
3.1
mmol/l
105.9
105.6
—
7
62
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
675
1.06
0.15
1.9
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
42
449
0.93
0.14
3.3
3.3
umol/l
7.3
8.6
0.43
34
400
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
98
0.81
0.14
1.3
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
170
1.12
0.13
1.7
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
474
1.06
0.12
2.0
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
27
250
1.08
0.11
1.7
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
108
1048
1.04
0.11
4.9
4.3
ph
7.4
7.4
0.44
24
201
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
168
1645
1.03
0.10
15.1
6.5
mmol/l
1.2
1.2
4.44
153
1482
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
166
1695
0.97
0.10
4.9
4.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
30
280
1.08
0.10
8.9
3.9
mmol/l
2.8
1.9
0.75
22
209
(3034860) Kappa light chains.free [Mass/volume] in Serum
11
125
0.88
0.10
3.5
4.0
mg/l
48.5
113.7
—
6
101
(3019832) Treponema pallidum Ab [Presence] in Serum
21
228
0.92
0.10
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
60
577
1.05
0.09
3.7
2.4
g/l
2.3
2.3
0.07
52
532
(3044640) Blood type and Crossmatch panel - Blood
120
1173
1.03
0.08
3.0
2.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
62
0.80
0.08
1.2
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
62
0.80
0.08
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
32
338
0.94
0.08
2.4
2.6
u/l
37.8
34.9
0.21
25
290
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
49
470
1.05
0.08
2.0
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
65
0.77
0.08
2.2
3.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
123
0.89
0.08
3.2
3.9
—
2.6
—
0
11
(3013826) Glucose [Moles/volume] in Serum or Plasma
221
2181
1.02
0.08
10.8
5.1
mmol/l
7.0
6.9
0.19
208
2043
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
520
0.96
0.08
1.8
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
71
0.84
0.07
1.0
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
82
0.85
0.07
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
85
0.82
0.07
1.4
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
85
0.82
0.07
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
86
1.05
0.07
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
295
0.95
0.06
4.9
3.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
104
0.86
0.06
2.1
1.3
—
—
—
0
0
(3000492) Spirometry study
33
317
1.04
0.05
1.6
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
545
1.03
0.05
4.1
2.5
%
20.5
22.9
0.73
46
464
(3042936) Bacteria identified in Isolate by Culture
58
568
1.02
0.03
2.9
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
772
0.98
0.03
2.0
1.7
mg/l
2.0
1.4
0.65
60
598
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
182
1812
1.01
0.01
13.0
7.2
mmol/l
1.2
1.2
3.38
150
1521
(3027945) Reticulocytes/100 erythrocytes in Blood
49
497
0.98
0.01
1.5
2.6
%
1.5
1.8
1.31
40
450
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
114
1.05
0.00
1.8
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
274
1.02
0.00
1.8
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
296
0.98
0.00
4.0
3.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
156
1.03
0.00
1.8
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
217
1.01
0.00
6.7
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
43
427
1.01
0.00
1.7
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
358
1.01
0.00
1.8
2.7
e9/l
59.1
68.3
1.30
28
282
(3052851) Hemolysis interference index of Serum or Plasma
12
119
1.01
0.00
3.6
3.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
169
1.01
0.00
1.1
1.2
iu/ml
120.2
172.4
—
6
55
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
881
1.00
0.00
3.0
2.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
29.2
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
97
0.93
0.00
4.2
2.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
5
0.00
0.00
0.0
9.6
—
31.2
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
51
0.98
0.00
2.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
21.6
—
0
8
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
1.0
—
0
7
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
1.1
—
0
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
50
1.00
0.00
2.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
24
240
1.00
0.00
1.4
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
60
1.00
0.00
1.8
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
89
1.01
0.00
4.0
4.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
26.1
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
69
0.87
0.00
1.2
1.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
58
0.86
0.00
1.6
1.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
60
1.00
0.00
3.5
2.4
u/ml
3.8
4.2
—
6
55
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
3.0
—
9113.5
—
0
8
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
73
0.96
0.00
2.4
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ANOXBRAINDAM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ANOXBRAINDAM | 5.632 [4.28, 7.42] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.638 |
During the follow-up period (1.1.1998 — 31.12.2019), 257 out of 594 females with G6_ANOXBRAINDAM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ANOXBRAINDAM | 4.447 [3.79, 5.22] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.062 |
During the follow-up period (1.1.1998 — 31.12.2019), 781 out of 1580 males with G6_ANOXBRAINDAM died.
Mortality risk
Mortality risk for people of age
years, who have G6_ANOXBRAINDAM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.472% | 1.023% |
| 5 | 3.401% | 5.482% |
| 10 | 9.156% | 13.608% |
| 15 | 16.581% | 24.711% |
| 20 | 27.016% | 40.035% |
Relationships between endpoints
↥Index endpoint: G6_ANOXBRAINDAM – Anoxic brain damage
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data